MB-CART19.1 in Refractory SLE

Clinical trial NCT06189157 · RECRUITING

Trial details

NCT number: NCT06189157
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus

Start date: 2024-08-12
Primary completion: 2027-09-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.